CA2244136A1 - 1-pyrazol-3-yl-ethyl-4-indol-3-yl-piperidine used as medicine acting on the central nervous system - Google Patents

1-pyrazol-3-yl-ethyl-4-indol-3-yl-piperidine used as medicine acting on the central nervous system Download PDF

Info

Publication number
CA2244136A1
CA2244136A1 CA002244136A CA2244136A CA2244136A1 CA 2244136 A1 CA2244136 A1 CA 2244136A1 CA 002244136 A CA002244136 A CA 002244136A CA 2244136 A CA2244136 A CA 2244136A CA 2244136 A1 CA2244136 A1 CA 2244136A1
Authority
CA
Canada
Prior art keywords
ethyl
methyl
indole
pyrazolyl
piperidyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002244136A
Other languages
English (en)
French (fr)
Inventor
Henning Bottcher
Joachim Marz
Gerd Bartoszyk
Hartmut Greiner
Jurgen Harting
Christoph Seyfried
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2244136A1 publication Critical patent/CA2244136A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
CA002244136A 1996-01-25 1997-01-17 1-pyrazol-3-yl-ethyl-4-indol-3-yl-piperidine used as medicine acting on the central nervous system Abandoned CA2244136A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19602505.2 1996-01-25
DE19602505A DE19602505A1 (de) 1996-01-25 1996-01-25 1-(Pyrazol-4-Indol-3-yl)-Piperidine

Publications (1)

Publication Number Publication Date
CA2244136A1 true CA2244136A1 (en) 1997-07-31

Family

ID=7783568

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002244136A Abandoned CA2244136A1 (en) 1996-01-25 1997-01-17 1-pyrazol-3-yl-ethyl-4-indol-3-yl-piperidine used as medicine acting on the central nervous system

Country Status (16)

Country Link
EP (1) EP0879234A1 (es)
JP (1) JP2000503972A (es)
KR (1) KR19990081970A (es)
CN (1) CN1209807A (es)
AR (1) AR005549A1 (es)
AU (1) AU715785B2 (es)
BR (1) BR9707467A (es)
CA (1) CA2244136A1 (es)
CZ (1) CZ231898A3 (es)
DE (1) DE19602505A1 (es)
HU (1) HUP9900980A2 (es)
NO (1) NO983439L (es)
PL (1) PL328228A1 (es)
SK (1) SK99298A3 (es)
WO (1) WO1997027186A1 (es)
ZA (1) ZA97572B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60009932T2 (de) * 1999-09-09 2005-04-14 H. Lundbeck A/S 5-aminoalkyl- und 5-aminocarbonylsubstituierte indole
MXPA02004647A (es) 1999-11-10 2002-10-31 Takeda Chemical Industries Ltd Compuestos heterociclicos de 5 miembros que contienen nitrogeno.
CN1329392C (zh) 2000-08-14 2007-08-01 奥索-麦克尼尔药品公司 取代的吡唑
US7332494B2 (en) 2000-08-14 2008-02-19 Janssen Pharmaceutica, N.V. Method for treating allergies using substituted pyrazoles
WO2003042208A1 (en) * 2001-11-14 2003-05-22 Merck Patent Gmbh Pyrazole derivatives as psychopharmaceuticals
EP1937688B1 (en) 2005-10-11 2010-08-11 F. Hoffmann-La Roche AG Imidazo benzodiazepine derivatives
EP1945213A4 (en) * 2005-10-24 2009-12-02 Janssen Pharmaceutica Nv MODULATORS OF THE R3-PIPERIDINE-4-YL-INDOLE ORL-1 RECEPTOR
TWI548630B (zh) 2011-04-06 2016-09-11 Lg生命科學有限公司 1-(3-氰基-1-異丙基-吲哚-5-基)吡唑-4-羧酸結晶型及其製造方法
KR20220060488A (ko) * 2020-11-04 2022-05-11 주식회사 엘지화학 1-(3-시아노-1-아이소프로필-인돌-5-일)피라졸-4-카르복실산의 결정성 입자의 제조방법 및 이를 포함하는 약학적 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2060816C3 (de) * 1970-12-10 1980-09-04 Merck Patent Gmbh, 6100 Darmstadt 4-Phenylpiperidinderivate Verfahren zu ihrer Herstellung und pharmazeutische Zubereitungen enthaltend diese Verbindungen
DE2258033A1 (de) * 1972-11-27 1974-05-30 Merck Patent Gmbh Verfahren zur herstellung von pyrazolderivaten
GB8719167D0 (en) * 1987-08-13 1987-09-23 Glaxo Group Ltd Chemical compounds
US5045550A (en) * 1990-09-20 1991-09-03 Warner-Lambert Co. Substituted tetrahydropyridines as central nervous system agents
US5521196A (en) * 1994-10-05 1996-05-28 Eli Lilly And Company 5-HT1F agonists for the treatment of migraine

Also Published As

Publication number Publication date
AR005549A1 (es) 1999-06-23
NO983439D0 (no) 1998-07-24
WO1997027186A1 (de) 1997-07-31
EP0879234A1 (de) 1998-11-25
AU1443297A (en) 1997-08-20
JP2000503972A (ja) 2000-04-04
CZ231898A3 (cs) 1998-10-14
ZA97572B (en) 1997-08-04
DE19602505A1 (de) 1997-07-31
PL328228A1 (en) 1999-01-18
KR19990081970A (ko) 1999-11-15
AU715785B2 (en) 2000-02-10
NO983439L (no) 1998-09-25
BR9707467A (pt) 1999-07-20
SK99298A3 (en) 1999-01-11
HUP9900980A2 (hu) 1999-07-28
CN1209807A (zh) 1999-03-03

Similar Documents

Publication Publication Date Title
RU2132848C1 (ru) Производные пиперидина и пиперазина, способ их получения, содержащие их фармацевтические композиции и способ их получения
US5698553A (en) Benzylpiperidine derivatives
RU2159238C2 (ru) Бензофураны и способ их получения
RU2168508C2 (ru) Бензонитрилы и бензофториды, способ их получения, фармацевтическая композиция, способ ее получения
KR100361950B1 (ko) 3-인돌릴피페리딘
EP0389861A1 (en) Benzopyran derivatives and processes for preparation thereof
US20130102783A1 (en) Substituted diketopiperazines and their use as oxytocin antagonists
JPH01265100A (ja) 2―置換アデノシン誘導体
KR20000005505A (ko) 피페리딘 및 피롤리딘
AU715785B2 (en) 1-(pyrazol-3-ylethyl)-4-(indol-3-yl) piperdines as compositions affecting the central nervous system
CA2128380C (en) 4-aryloxy- and 4-arylthiopiperidine derivatives
JP2000505096A (ja) 抗腫瘍剤としてのアリールスルホニルイミダゾロン誘導体
KR100384978B1 (ko) 유착수용체길항물질
JP2886570B2 (ja) 縮合ヘテロ環を有する化合物
JPH0699420B2 (ja) 水素添加された1−ベンゾオキサシクロアルキルピリジンカルボン酸化合物,その製造方法及び該化合物を含む医薬製剤
KR100384261B1 (ko) 나프틸옥시아세트산유도체
RU2175970C2 (ru) Производные пиперидинилметилоксазолидин-2-она, способ их получения и фармацевтическая композиция на их основе
FR2758329A1 (fr) Derives d'imidazole-4-butane boronique, leur preparation et leur utilisation en therapeutique
HU218274B (en) N,n'-bis hydroxyalkyl and alkoxyalkyl-pyridine-2,4-dicarboxylic acid diamide derivatives and pharmaceutical compositions comprising such compounds and process for producing them
JPS59118784A (ja) 置換イミダゾ〔1,5−a〕ピリジン及びその製造方法,並びに該化合物を含有する医薬
MXPA96003567A (es) Derivados de la piperidinilmetiloxazolidin-2-ona
EP0602458A1 (en) 1,4-Benzoxazine derivatives
KR890003357B1 (ko) 신규 티아졸 화합물의 제조방법
JPS62226977A (ja) ピリジン誘導体
JPH0673008A (ja) アンジオテンシンii拮抗性ピリジン誘導体

Legal Events

Date Code Title Description
FZDE Discontinued